JPM, NFLX kick off the reporting season
The earnings season kicks into high gear this week, at a time when investors may be starving for…
How The Narrative On Johnson & Johnson (JNJ) Is Shifting With New Targets And Litigation Risks
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
Trump tariffs fall, but trade war impacts linger
A year after President Donald Trump declared his “liberation day” and imposed sweeping tariffs on imports, kicking off…
ICOTYDE Approval Adds New Growth Angle To Johnson & Johnson Valuation Story
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million…
FDA accepts BMS protein degrader for review; Disc rare disease drug rejected
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
More drugs should be over-the-counter
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
Is Johnson & Johnson a Buy, Sell, or Hold in 2026?
While artificial intelligence (AI) stocks are dominating debates and headlines on Wall Street, companies in other sectors can…
Robotic surgery fuels Johnson & Johnson dividend growth outlook
Johnson & Johnson (JNJ) just made a move that investors have been waiting years to see. The healthcare…
J&J wants to be the leader in the cancer fight. Its strategy is starting to pay off as oncology sales top $25 billion in 2025.
Last Updated: Jan. 21, 2026 at 10:14 a.m. ETFirst Published: Jan. 21, 2026 at 7:26 a.m. ET Johnson & Johnson…
Stock market today: Live updates
Traders work on the floor at the New York Stock Exchange, Jan. 20, 2026. Michael Nagle | Bloomberg…
Johnson & Johnson (JNJ) Q4 earnings
Johnson & Johnson said on Thursday that it has reached an agreement with the U.S. President administration to…
Stock market today: Live updates
Trades work at the New York Stock Exchange on Jan. 16, 2026. NYSE Stock futures on Monday night…